$2.24T
Total marketcap
$73.47B
Total volume
BTC 56.29%     ETH 8.99%
Dominance
Perrigo Company

Perrigo Company PRGO Stock

$9.49   -1.145840%
Add to favorites
Exchange
Market Cap
$1.31B
LOW - HIGH [24H]
$9.39 - $9.75
VOLUME [24H]
$2.75M
P/E Ratio
0
Earnings per share
-$12.92
ISIN
IE00BGH1M568
Price   Prediction

Perrigo Company Price Chart

Sorry, that's all we've gotfor now...

Perrigo Company PRGO Financial and Trading Overview

Perrigo Company stock price 9.49 USD
Previous Close 10.25 USD
Open 10.11 USD
Bid 9.6 USD x 270000
Ask 9.73 USD x 120000
Day's Range 9.58 - 10.2 USD
52 Week Range 9.23 - 28.44 USD
Volume 2.64M USD
Avg. Volume 2.94M USD
Market Cap 1.33B USD
Beta (5Y Monthly) 0.516
PE Ratio (TTM) N/A
EPS (TTM) -12.93 USD
Forward Dividend & Yield 1.16 (11.31%)
Ex-Dividend Date May 29, 2026
1y Target Est 16.5 USD

PRGO Valuation Measures

Enterprise Value 4.8B USD
Trailing P/E N/A
Forward P/E 4.0643525
PEG Ratio (5 yr expected) 1.14
Price/Sales (ttm) 0.31790417
Price/Book (mrq) 0.53056264
Enterprise Value/Revenue 1.149
Enterprise Value/EBITDA 7.532

Trading Information

Perrigo Company Stock Price History

Beta (5Y Monthly) 0.516
52-Week Change -61.24%
S&P500 52-Week Change 24.48%
52 Week High 28.44 USD
52 Week Low 9.23 USD
50-Day Moving Average 11.19 USD
200-Day Moving Average 14.54 USD

PRGO Share Statistics

Avg. Volume (3 month) 2.94M USD
Avg. Daily Volume (10-Days) 3.9M USD
Shares Outstanding 138.37M
Float 137.62M
Short Ratio 5.95
% Held by Insiders 0.39%
% Held by Institutions 116.52%
Shares Short 15.07M
Short % of Float 16.73%
Short % of Shares Outstanding 10.89%

Dividends & Splits

Trailing Annual Dividend Rate 1.16
Trailing Annual Dividend Yield 11.31%
5 Year Average Dividend Yield 404.00%
Payout Ratio 109.5
Last Split Factor 2:1

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2025
Most Recent Quarter (mrq) March 28, 2026
Next Fiscal Year End December 31, 2026

Profitability

Profit Margin -43.50%
Operating Margin (ttm) 3.46%
Gross Margin 34.16%
EBITDA Margin 15.25%

Management Effectiveness

Return on Assets (ttm) 2.08%
Return on Equity (ttm) -52.23%

Income Statement

Revenue (ttm) 4.18B USD
Revenue Per Share (ttm) 30.12 USD
Quarterly Revenue Growth (yoy) -7.19%
Gross Profit (ttm) 1.43B USD
EBITDA 637.3M USD
Net Income Avi to Common (ttm) -1792300032 USD
Diluted EPS (ttm) -12.93
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 357.2M USD
Total Cash Per Share (mrq) 2.58 USD
Total Debt (mrq) 3.83B USD
Total Debt/Equity (mrq) 153.22 USD
Current Ratio (mrq) 2.719
Book Value Per Share (mrq) 18.094

Cash Flow Statement

Operating Cash Flow (ttm) 189.4M USD
Levered Free Cash Flow (ttm) 108.43M USD

Profile of Perrigo Company

Country United States
State N/A
City Dublin
Address The Sharp Building
ZIP D02 TY74
Phone 353 1 709 4000
Website https://www.perrigo.com
Industry Drug Manufacturers - Specialty & Generic
Sector(s) Healthcare
Full Time Employees 8100

Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally. The company operates through Consumer Self-Care Americas and Consumer Self-Care International segments. It offers upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and oral electrolyte beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers. The company also offers healthy lifestyle products, such as smoking cessation and well-being products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women's health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; and other miscellaneous self-care products. It sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, and Compeed brands. The company also offers contract manufacturing services. It sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies. The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.

Q&A For Perrigo Company Stock

What is a current PRGO stock price?

Perrigo Company PRGO stock price today per share is 9.49 USD.

How to purchase Perrigo Company stock?

You can buy PRGO shares on the NYSE exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Perrigo Company?

The stock symbol or ticker of Perrigo Company is PRGO.

Which industry does the Perrigo Company company belong to?

The Perrigo Company industry is Drug Manufacturers - Specialty & Generic.

How many shares does Perrigo Company have in circulation?

The max supply of Perrigo Company shares is 138.37M.

What is Perrigo Company Price to Earnings Ratio (PE Ratio)?

Perrigo Company PE Ratio is now.

What was Perrigo Company earnings per share over the trailing 12 months (TTM)?

Perrigo Company EPS is -12.93 USD over the trailing 12 months.

Which sector does the Perrigo Company company belong to?

The Perrigo Company sector is Healthcare.

Perrigo Company PRGO included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
{{ item.symbol }} {{ item.name }} {{ item.symbol }} {{ item.country.toUpperCase() }} {{ item.price }} {{ item.price_usd }}
{{ item.change_pct }}
{{ item.volume }} {{ item.volume_usd }} {{ item.low }} {{ item.low_usd }} {{ item.high }} {{ item.high_usd }} {{ item.components_count }} {{ item.volume }} {{ item.volume_usd }}
us US Tech US Smart Pharmaceuticals NQSSPH US 1926.14 USD
+1.34
1902.55 USD 1929.69 USD
us NYSE Arca Pharmaceutical Index DRG US 1176.89 USD
+1.89
us US Tech US Broad Dividend Achiev DAA US 4461.52 USD
-0.26
4444.29 USD 4474.67 USD
us NYSE Composite Index NYA US 23463.63 USD
-0.56
us US Tech DM Ex Japan Large Mid Ca NQDMXJPLMAUD US 2100.38 AUD 1467.26 USD
<0.01
2100.38 AUD 1467.26 USD 2100.38 AUD 1467.26 USD
us US Tech US Broad Dividend Achiev DAATR US 8363.59 USD
-0.25
8331.29 USD 8388.24 USD
Select currency